Polymeric-based perivascular delivery of a nitric oxide donor inhibits intimal thickening after balloon denudation arterial injury: role of nuclear factor-kappaB.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Journal of the American College of Cardiology

• Publication date

  2000-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0735-1097(99)00543-4PMID 10676700
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Perivascular delivery of a nitric oxide donor inhibits neointimal hyperplasia in vein grafts implanted in the arterial circulation.

  1998cited by this paper
• Pro-inflammatory signaling: last pieces in the NF-kappaB puzzle?

  1998cited by this paper
• Drug clearance and arterial uptake after local perivascular delivery to the rat carotid artery.

  1997cited by this paper
• Nuclear factor-κB activity and arterial response to balloon injury

  1997cited by this paper
• Comparison of a bioabsorbable GTR barrier to a non-absorbable barrier in treating human class II furcation defects. A multi-center parallel design randomized single-blind trial.

  1997cited by this paper
• Local Delivery of an Ultra-short-acting Nitric Oxide- releasing Compound, DMHD/NO, Is Highly Effective in Inhibiting Acute Platelet-Thrombus Formation on Injured Arterial Strips

  1997cited by this paper
• Nuclear factor-kappaB activity and arterial response to balloon injury.

  1997cited by this paper
• Inhibition of NF-kappaB DNA binding by nitric oxide.

  1996cited by this paper
• Controlled delivery of a tyrphostin inhibits intimal hyperplasia in a rat carotid artery injury model.

  1996cited by this paper
• Nitric Oxide Attenuates Vascular Smooth Muscle Cell Activation by Interferon-

  1996cited by this paper
• Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries.

  1996cited by this paper
• "NONOates" (1-substituted diazen-1-ium-1,2-diolates) as nitric oxide donors: convenient nitric oxide dosage forms.

  1996cited by this paper
• Chronic inhalation of nitric oxide inhibits neointimal formation after balloon-induced arterial injury.

  1996cited by this paper
• Nitric oxide reversibly inhibits the migration of cultured vascular smooth muscle cells.

  1996cited by this paper
• Transcriptional activation of the macrophage-colony stimulating factor gene by minimally modified LDL. Involvement of nuclear factor-kappa B.

  1995cited by this paper
• Nitroglycerin decreases medial smooth muscle cell proliferation after arterial balloon injury.

  1995cited by this paper
• Transcriptional activation of the macrophage-colony stimulating factor gene by minimally modified LDL : involvement of nuclear factor-κB

  1995cited by this paper
• Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene.

  1995cited by this paper
• Induction and stabilization of I kappa B alpha by nitric oxide mediates inhibition of NF-kappa B.

  1995cited by this paper
• Nitric oxide-generating compounds inhibit total protein and collagen synthesis in cultured vascular smooth muscle cells.

  1995cited by this paper
• Nitric Oxide (NO) Donor Molecules: Effect of NO Release Rate on Vascular Smooth Muscle Cell Proliferation In Vitro

  1995cited by this paper
• Restenosis after percutaneous transluminal coronary angioplasty: have we been aiming at the wrong target?

  1995cited by this paper
• Induction and Stabilization of IκBα by Nitric Oxide Mediates Inhibition of NF-κB (*)

  1995cited by this paper
• Gene therapy inhibiting neointimal vascular lesion

  1995cited by this paper
• Antithrombotic actions of argatroban in rat models of venous, ‘mixed’ and arterial thrombosis, and its effects on the tail transection bleeding time

  1994cited by this paper
• Vascular smooth muscle cells express a constitutive NF-kappa B-like activity.

  1994cited by this paper
• Localized Arterial Wall Drug Delivery From a Polymer‐Coated Removable Metallic Stent: Kinetics, Distribution, and Bioactivity of Forskolin

  1994cited by this paper
• Beneficial effect of SPM-5185, a cysteine-containing nitric oxide donor, in rat carotid artery intimal injury.

  1994cited by this paper
• Local delivery of dexamethasone for prevention of neointimal proliferation in a rat model of balloon angioplasty.

  1994cited by this paper
• Complexes of Nitric Oxide with Nucleophiles as Agents for the Controlled Biological Release of Nitric Oxide: Hemodynamic Effect in the Rabbit

  1993cited by this paper
• Effect of controlled adventitial heparin delivery on smooth muscle cell proliferation following endothelial injury.

  1990cited by this paper
• An L-arginine/nitric oxide pathway present in human platelets regulates aggregation.

  1990cited by this paper
• Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells.

  1989cited by this paper
• Restenosis after percutaneous transluminal coronary angioplasty.

  1988cited by this paper

• Efficacy of Nitric Oxide-Releasing Nanofibers in Reducing Renal Ischemia-Reperfusion Injury in a Rat Model

  2022cites this paper
• The Evolution of Nitric Oxide Function: From Reactivity in the Prebiotic Earth to Examples of Biological Roles and Therapeutic Applications

  2022cites this paper
• Nitrile-Functionalized Poly(2-oxazoline)s as a Versatile Platform for the Development of Polymer Therapeutics.

  2021cites this paper
• Increase of wall shear stress caused by arteriovenous fistula reduces neointimal hyperplasia after stent implantation in healthy arteries

  2020cites this paper
• Therapeutic Applications and Mechanisms of YC-1: A Soluble Guanylate Cyclase Stimulator

  2019cites this paper
• Gaso-Transmitters Nitric oxide : what ’ s new to NO ?

  2017cites this paper
• Perivascular medical devices and drug delivery systems: Making the right choices.

  2017cites this paper
• Role of macrophage colony-stimulating factor in the development of neointimal thickening following arterial injury.

  2016cites this paper
• Nitric Oxide-Releasing Biomaterials for Biomedical Applications.

  2016cites this paper
• Nitric oxide as a surgical adjuvant

  2015cites this paper
• Nitric Oxide Delivery: Restenosis Prevention

  2015cites this paper
• Nitric Oxide-Releasing Biomedical Materials

  2015cites this paper
• Role of metabolic environment on nitric oxide mediated inhibition of neointimal hyperplasia in type 1 and type 2 diabetes.

  2014cites this paper
• Nuclear Imaging in Cardiovascular Medicine

  2013cites this paper
• In vitro and in vivo study of sustained nitric oxide release coating using diazeniumdiolate-oped poly(vinyl chloride) matrix with poly(lactide-co-glycolide) additive.

  2013cites this paper
• Nitric Oxide Delivery for Prevention of Restenosis

  2012cites this paper
• Pathology of Sudden Death in Coronary Arterial Diseases

  2012cites this paper
• Nitric oxide and nitrite-based therapeutic opportunities in intimal hyperplasia.

  2012cites this paper
• The role of estrogen receptor α and β in regulating vascular smooth muscle cell proliferation is based on sex.

  2012cites this paper
• Polymer‐Based Nitric Oxide Therapies: Recent Insights for Biomedical Applications

  2012cites this paper
• Impact of Parallel Micro-Engineered Stent Grooves on Endothelial Cell Migration, Proliferation, and Function: An In Vivo Correlation Study of the Healing Response in the Coronary Swine Model

  2012cites this paper
• Insights into the effect of nitric oxide and its metabolites nitrite and nitrate at inhibiting neointimal hyperplasia.

  2011cites this paper
• ASSOCIATION FOR ACADEMIC SURGERY Nitric Oxide Increases Lysine 48-Linked Ubiquitination Following Arterial Injury 1

  2011cites this paper
• Nitric oxide increases lysine 48-linked ubiquitination following arterial injury.

  2011cites this paper
• Poly(diol-co-citrate)s as novel elastomeric perivascular wraps for the reduction of neointimal hyperplasia.

  2011cites this paper
• Modifying biomaterial surfaces to optimise interactions with blood

  2010cites this paper
• NO-loaded Zn(2+)-exchanged zeolite materials: a potential bifunctional anti-bacterial strategy.

  2010cites this paper
• Insulin enhances the effect of nitric oxide at inhibiting neointimal hyperplasia in a rat model of type 1 diabetes.

  2010cites this paper
• Medicinal Chemistry and Therapeutic Applications of the Gasotransmitters NO, CO, and H2S and their Prodrugs

  2010cites this paper
• Nitric oxide regulates the 26 S proteasome in vascular smooth muscle cells

  2009cites this paper
• Novel Nitric Oxide Donors for Use in Medicinal Applications

  2009cites this paper
• Current advances in research and clinical applications of PLGA-based nanotechnology

  2009cites this paper
• Nitric oxide regulates the 26S proteasome in vascular smooth muscle cells.

  2009cites this paper
• Heightened efficacy of nitric oxide-based therapies in type II diabetes mellitus and metabolic syndrome.

  2008cites this paper
• Polyurethane with tethered copper(II)-cyclen complex: preparation, characterization and catalytic generation of nitric oxide from S-nitrosothiols.

  2008cites this paper
• Nitric oxide-releasing polyurethane-PEG copolymer containing the YIGSR peptide promotes endothelialization with decreased platelet adhesion.

  2008cites this paper
• Nitric oxide and nanotechnology: a novel approach to inhibit neointimal hyperplasia.

  2008cites this paper
• Beneficial effect of a short-acting NO donor for the prevention of neointimal hyperplasia.

  2008influential citation
• Biofunctionalization of biomaterials for accelerated in situ endothelialization: a review.

  2008cites this paper
• Recent developments in nitric oxide donor drugs

  2007cites this paper
• Enhanced External Counterpulsation Inhibits Intimal Hyperplasia by Modifying Shear Stress–Responsive Gene Expression in Hypercholesterolemic Pigs

  2007cites this paper
• Enhanced External Counterpulsation Inhibits Intimal Hyperplasia by Modifying Shear Stress–Responsive Gene Expression in Hypercholesterolemic Pigs Molecular Cardiology

  2007cites this paper
• In Vivo Reduction of the Nuclear Factor-κB Activity Using Synthetic cis-Element Decoy Oligonucleotides Suppresses Intimal Hyperplasia in the Injured Carotid Arteries in Rabbits

  2007cites this paper
• Nitric Oxide: What a Vascular Surgeon Needs to Know

  2007influential citation
• The role of nitric oxide in the pathophysiology of intimal hyperplasia.

  2007cites this paper
• The Role of Periadventitial Fat in Atherosclerosis An Adipose Subset With Potential Diagnostic and Therapeutic Implications

  2007cites this paper
• Nitric Oxide Generating Polymers (NOGPs).

  2007cites this paper
• The role of periadventitial fat in atherosclerosis.

  2007cites this paper
• Vascular grafts and the endothelium.

  2006cites this paper
• Perivascular paclitaxel wraps block arteriovenous graft stenosis in a pig model.

  2006cites this paper
• Development of a Local Perivascular Paclitaxel Delivery System for Hemodialysis Vascular Access Dysfunction: Polymer Preparation and in vitroActivity

  2006cites this paper
• EARLY ACTIVATION OF INTERNAL MEDIAL SMOOTH MUSCLE CELLS IN THE RABBIT AORTA AFTER MECHANICAL INJURY: RELATIONSHIP WITH INTIMAL THICKENING AND PHARMACOLOGICAL APPLICATIONS

  2006cites this paper
• Solutions for Hemodialysis Vascular access Dysfunction: Thinking out of the Box!!

  2005cites this paper
• Reduced cGMP signaling activates NF-kappaB in hypertrophied hearts of mice lacking natriuretic peptide receptor-A.

  2005cites this paper
• Synthesis, characterization, and controlled nitric oxide release from S-nitrosothiol-derivatized fumed silica polymer filler particles.

  2005cites this paper
• Long-term treatment with the NO-donor molsidomine reduces circulating ICAM-1 levels in patients with stable angina.

  2005cites this paper
• Vascular access in hemodialysis: issues, management, and emerging concepts.

  2005cites this paper
• Nitric oxide-producing polyurethanes.

  2005cites this paper
• Nitric oxide (NO)- and nitroxyl (HNO)-generating diazeniumdiolates (NONOates): emerging commercial opportunities.

  2005cites this paper
• Isolated left ventricular non-compaction in a patient with pre-excited atrial fibrillation.

  2005cites this paper
• Controlled photoinitiated release of nitric oxide from polymer films containing S-nitroso-N-acetyl-DL-penicillamine derivatized fumed silica filler.

  2004cites this paper
• Novel Therapies for Hemodialysis Vascular Access Dysfunction: Fact or Fiction!

  2004cites this paper
• Controlled photochemical release of nitric oxide from O2-substituted diazeniumdiolates.

  2004cites this paper
• Nitrosative Stress and Transcription

  2003cites this paper
• Progress toward clinical application of the nitric oxide-releasing diazeniumdiolates.

  2003cites this paper
• Augmentation of Intrapericardial Nitric Oxide Level by a Prolonged-Release Nitric Oxide Donor Reduces Luminal Narrowing After Porcine Coronary Angioplasty

  2002cites this paper
• Synthesis and characterization of polymethacrylate-based nitric oxide donors.

  2002cites this paper
• Direct Estrogen Effects on the Cardiovascular System

  2002cites this paper
• Atherosclerosis and thrombus

  2002cites this paper
• Assessment of peripheral arterial vascular disease with radionuclide techniques.

  2001cites this paper
• New developments in the detection of vulnerable plaque

  2001cites this paper
• Nitric oxide and postangioplasty restenosis: pathological correlates and therapeutic potential.

  2000cites this paper
• ‘POPE’: Predicting outcome by plaque evaluation

  2000cites this paper
• YC-1, a benzyl indazole derivative, stimulates vascular cGMP and inhibits neointima formation.

  2000cites this paper